de Bruin N M, Ellenbroek B A, van Luijtelaar E L, Cools A R, Stevens K E
NICI Department of Psychoneuropharmacology, University of Nijmegen, The Netherlands.
Neuroscience. 2001;105(1):169-80. doi: 10.1016/s0306-4522(01)00183-x.
Sensory processing disturbances, as measured in the P50/sensory gating paradigm, have been linked to aberrant auditory information processing and sensory overload in schizophrenic patients. In this paradigm, the response to the second of paired-click stimuli is attenuated by an inhibitory effect of the first stimulus. Sensory gating has been observed in most healthy human subjects and normal laboratory rats. Because mesolimbic dopamine has been implicated in other filtering disturbances such as prepulse inhibition of the acoustic startle response and given the fact that amphetamine and apomorphine have been shown to disrupt gating, this study was performed to investigate the role of mesolimbic dopamine in sensory gating. The dopamine D2 receptor agonist quinpirole (10 microg/0.5 microl) was injected bilaterally in nucleus accumbens core and shell and effects on cortical and hippocampal sensory gating were investigated. Also, effects of the dopamine D2 receptor antagonist haloperidol (0.1 mg/kg, subcutaneously) as pretreatment were studied. First, quinpirole significantly reduced both the amplitude to the first click and gating as measured in the cortex and in the hippocampus. There was a tendency for the quinpirole effects on hippocampal gating to be more pronounced in rats injected in the shell. Secondly, haloperidol did not antagonize effects of quinpirole on hippocampal parameters, whereas haloperidol pretreatment fully antagonized quinpirole effects on cortical parameters. In conclusion, gating can be significantly reduced when a dopamine agonist is specifically targeted at mesolimbic dopamine D2 receptors. However, an important consideration is that the dopaminergic effects in the present study on gating are predominantly mediated by the effects on the amplitude to the first click. This has also been suggested for systemic amphetamine injections in rats and schizophrenic patients. This casts doubt on whether dopamine receptor activation affects the putative inhibitory process between the first and the second stimulus.
在P50/感觉门控范式中所测量的感觉加工障碍,已被认为与精神分裂症患者异常的听觉信息处理和感觉超负荷有关。在此范式中,对成对点击刺激中的第二个刺激的反应会因第一个刺激的抑制作用而减弱。在大多数健康人类受试者和正常实验大鼠中都观察到了感觉门控。由于中脑边缘多巴胺与其他过滤障碍有关,如对听觉惊吓反应的前脉冲抑制,并且鉴于已表明苯丙胺和阿扑吗啡会破坏门控,因此进行本研究以探讨中脑边缘多巴胺在感觉门控中的作用。将多巴胺D2受体激动剂喹吡罗(10微克/0.5微升)双侧注射到伏隔核核心和壳部,并研究其对皮质和海马感觉门控的影响。此外,还研究了多巴胺D2受体拮抗剂氟哌啶醇(0.1毫克/千克,皮下注射)作为预处理的效果。首先,喹吡罗显著降低了皮质和海马中所测量的对第一个点击的振幅以及门控。在注射到壳部的大鼠中,喹吡罗对海马门控的影响有更明显的趋势。其次,氟哌啶醇并未拮抗喹吡罗对海马参数的影响,而氟哌啶醇预处理完全拮抗了喹吡罗对皮质参数的影响。总之,当多巴胺激动剂特异性作用于中脑边缘多巴胺D2受体时,门控可被显著降低。然而,一个重要的考虑因素是,本研究中多巴胺能对门控的影响主要是通过对第一个点击振幅的影响来介导的。这在对大鼠和精神分裂症患者进行全身苯丙胺注射时也得到了提示。这使人怀疑多巴胺受体激活是否影响第一个和第二个刺激之间假定的抑制过程。